State of Wisconsin Investment Board’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

State of Wisconsin Investment Board’s Portfolio MACK Stock Details MACK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-13,726	Closed	-$87K	–	1544
2018 Q1	$87K	Hold	13,726	–	–	﹤0.01%	1435
2017 Q4	$111K	Hold	13,726	–	–	﹤0.01%	1419
2017 Q3	$157K	Sell	13,726 -1	-0%	-$11	﹤0.01%	1417
2017 Q2	$134K	Buy	+13,727	New	+$280K	﹤0.01%	1427
2015 Q4	–	Sell	-38,130	Closed	-$2.55M	–	1346
2015 Q3	$2.55M	Buy	+38,130	New	+$3.11M	0.01%	1035

Other funds holding MACK

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

TCIM

TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return

WIM

Wittenberg Investment Management Carlisle, Massachusetts $269M AUM 28.17% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State of Wisconsin Investment Board's MACK Position: Q2 2018 in Review

State of Wisconsin Investment Board sold out of Merrimack Pharmaceuticals, Inc. (MACK) in Q2 2018, closing a stake of 13,726 shares — an estimated $87K sold.

State of Wisconsin Investment Board first reported a position in MACK in Q3 2015 and held it in 5 quarters. The position peaked at $2.55M in Q3 2015. 76 funds tracked by Wall St. Rank hold MACK as of Q2 2018.

State of Wisconsin Investment Board reported no remaining Merrimack Pharmaceuticals, Inc. position as of Q2 2018 after selling out during the quarter.
State of Wisconsin Investment Board sold 13,726 Merrimack Pharmaceuticals, Inc. shares in Q2 2018, an estimated $87K.
State of Wisconsin Investment Board first reported a position in Merrimack Pharmaceuticals, Inc. in Q3 2015 and held it in 5 quarters.
State of Wisconsin Investment Board's Merrimack Pharmaceuticals, Inc. position peaked at $2.55M in Q3 2015.
76 funds tracked by Wall St. Rank held Merrimack Pharmaceuticals, Inc. as of Q2 2018.

Based on State of Wisconsin Investment Board's 13F filing for Q2 2018, filed 3 Aug 2018.